we've seen already in the initial decision not to recommend AZ for over-65s (because the efficacy data from the clinical trials was too patchy at the time). Again, that's a defensible approach, but it is open to criticism during an urgent public health crisis. /7

— Oliver Moody (@olivernmoody) March 15, 2021